Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2013 by Peking Union Medical College.
Recruitment status was  Not yet recruiting
Information provided by (Responsible Party):
LI Taisheng, Peking Union Medical College Identifier:
First received: August 25, 2012
Last updated: April 26, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)